India’s Biopharma Shakti: How Budget 2026 Is Rebuilding the Nation’s Pharmaceutical and Medical Education Backbone
India’s Biopharma Shakti under Budget 2026 invests Rs 10,000 crore to expand NIPERs, establish 1,000 clinical trial sites, boost biosimilars, and train 1.5 lakh caregivers, aiming to transform India into a global pharmaceutical innovation hub. India is making its most ambitious bet yet on becoming a global biopharma powerhouse. Finance Minister Nirmala Sitharaman, presenting the…